KHALED AHMED ELSAID
Pharmacy in Wakefield, RI
License number
Rhode Island PHL03130
Issued Date
5, 2005
Expiration Date
6, 2006
Category
Pharmacy
Type
Pharmacist Limited (Intern)
Address
Address
Wakefield, RI
Education
UNIVERSITY OF RHODE ISLAND, 5, 1997
Professional information
See more information about KHALED AHMED ELSAID at trustoria.com
Methods Of Treatment For Injured Or Diseased Joints
Methods Of Treatment For Injured Or Diseased Joints
US Patent:
2008013, Jun 12, 2008
Filed:
Dec 1, 2005
Appl. No.:
11/792259
Inventors:
Gregory D. Jay - Norfolk MA, US
Khaled A. Elsaid - Kingston RI, US
Khaled A. Elsaid - Kingston RI, US
International Classification:
A61K 38/14, A61P 19/02
US Classification:
514 8
Abstract:
The invention features pharmaceutical compositions that include lubricin, a compound that inhibits an enzyme selected from the group consisting of neutrophil elastase, cathepsin B, cathepsin K, cathepsin L, cathepsin S, papain, trypsin, chymotrypsin, subtilisin, pepsin, bromelain, ficin, Protease A, Protease B, Protease D, granzyme A, granzyme B, granzyme K, pepsin, thermolysin, pronase, dipeptidyl peptidase IV, and pancreatin, and a pharmaceutically acceptable excipient. Another aspect of the invention features methods of lubricating a joint in a mammal by contacting the joint with a pharmaceutical composition of the invention. The invention also features methods of inhibiting adhesion formation between a first surface and a second surface in a mammal (e.g., between injured tissues or between injured tissue and an artificial device).
Treatment And Prevention Of Joint Disease
Treatment And Prevention Of Joint Disease
US Patent:
2009010, Apr 23, 2009
Filed:
Sep 18, 2008
Appl. No.:
12/284025
Inventors:
Gregory D. Jay - Norfolk MA, US
Khaled A. Elsaid - Kingston RI, US
Khaled A. Elsaid - Kingston RI, US
International Classification:
A61K 38/20, A61K 39/395, A61K 31/711, A61P 19/02
US Classification:
424 852, 4241301, 514 44
Abstract:
The invention provides compositions and methods for preserving, prolonging, or augmenting joint lubrication by contacting a tissue of a joint such as a knee, elbow, or other articulating joint, with a tribonectin and an inhibitor of a proinflammatory mediator.